Abhinav Humar, MD

Abhinav Humar, MD

N725 Montefiore
3459 Fifth Avenue
Pittsburgh, PA 15213

Liver-Related Work

Clinical and Research Interests: Areas of research include partial liver transplants (including living and deceased donor liver transplants) and studies of hepatic regeneration; clinical outcome studies in kidney, liver, intestine, and pancreas transplants; cytomegalovirus (CMV) disease in transplant recipients.
Ongoing Research Studies:
  1. Evaluation of Donor Specific Immune Senescence and Exhaustion as Biomarkers of Operational Tolerance Following Liver Transplantation in Adults (ITN Sponsored Trial).
  2. Observational, Post-marketing Renal Safety Surveillance Registry in Patients with Chronic Hepatitits B (HBV) Infection with Decompensated Liver Disease Receiving Nucleotide/side Therapy. 
  3. An Evauation of the Safety and Preliminary Efficacy of Perioperative Treprostinil in Preventing Ischemia and Reperfusion Injury in Adult Orthopedic Liver Transplant Recipients (Investigator Initiated).
  4. Phase I, Randomized, Open-Label, Active-Controlled, Dose Escalation Study to Evaluate the Safety, Tolerability, and Immunogenicity of INO-1800 Alone or in Combination With INO-9112 Delivered IM followed by Electroporation in Select Nucleos(t)ide Analogue-Treated, Chronic Hepatitis B Patients (Inovio Pharmaceuticals- Sponsored Trial).
  5. A2ALL: Adult-to-Adult Living Donor Liver Transplant Core Protocol (ITN/NIDDK Sponsored Trial)
  6. LIVE-C-FREE (LIVEr transplant for hepatitis C: recurrence FREE) Early and late treatment of Hepatitis C with Sofosbuvir/Ledipasvir in Liver Transplant Recipients (Sponsored by MUSC/Kenneth Chavin M.D).
Research Service: STI performs clinical research related to outcomes in transplant patients including performing observational and interventional studies.

 

Division Chief, Transplant Surgery
Department of Surgery